Background The role of mineralocorticoid receptor antagonists (MRAs) in acute myocardial infarction (MI) remains controversial, with conflicting evidence from landmark trials. We aimed to assess the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback